BIO KEY INTERNATIONAL INC
Close on Oct 19, 2026
- Market cap
- $2.35M
- P/E (TTM)
- –
- Dividend yield
- –
About Bio Key International
Services-Prepackaged Software, SIC 7372
BIO-key International, Inc. provides identity and access management platforms, multi-factor authentication, and biometric security software. Its principal offerings include PortalGuard and PortalGuard Identity-as-a-Service for enterprise workforce and customer identity, WEB-key civil identity infrastructure, and the MobileAuth mobile authentication application. The company also produces compact fingerprint scanners and FIDO-compliant hardware, as well as software development kits and application programming interfaces that embed biometric authentication into third-party software. BIO-key serves enterprise, education, and government clients, including healthcare systems, law enforcement agencies, defense forces, and original equipment manufacturers.
The company operates globally, serving over 600 customers across multiple industries as of December 31, 2025. It maintains direct sales operations and an international channel network spanning Europe, the Middle East, and Africa, with direct offices in Madrid, Spain and Lisbon, Portugal, alongside factory contractors in China. BIO-key is headquartered in Holmdel, New Jersey.
Summary of the business section of Bio Key International's latest annual report, written by StockData.
Company profile
Company
- Legal name
- BIO KEY INTERNATIONAL INC
- Founded
- 1993
- Headquarters
- Holmdel, NJ
- Address
- 101 Crawfords Corner Rd, Suite 4116 07733
- Phone
- (732) 359-1100
- Employees
- 42, Dec 31, 2025
- Industry
- Services-Prepackaged Software
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Bush and Associates CPA., Henderson, Nevada
Stock & identifiers
- Ticker
- BKYI
- Exchange
- Nasdaq
- IPO date
- Feb 21, 1997
- Shares outstanding
- 1M, Aug 11, 2026
- Public float
- $4.93M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-10 reverse, Jun 12, 2026; 1-for-10 reverse, Apr 30, 2026; 1-for-16 reverse, Jun 5, 2024; 1-for-18 reverse, Dec 21, 2023; 1-for-8 reverse, Nov 20, 2020; 1-for-12 reverse, Dec 29, 2016; 2-for-1, Jul 25, 1997
- SEC CIK
- 1019034
- CUSIP
- 09060C606
- ISIN
- US09060C6066
- LEI
- 549300VFT6WAQB4BVB07
- EIN
- 41-1761861
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Michael W. Depasquale | Chief Executive Officer, Director | 10,778 |
| Fong Wong Kwok | Managing Director, BIO-key HK | 35,248 |
| James David Sullivan | Chief Legal Officer | 425,586 |
| Mira K. Lacous | Chief Technology Officer | 4,076 |
| Cecilia C. Welch | Chief Financial Officer | 59,396 |
| Robert J. Michel | Director | 23,569 |
| Emmanuel Alia | Director | 21,323 |
| Cameron E. Williams | Director | 21,950 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Michael W. DePasquale | $346.82K | $309.43K | $348.20K | $5 | – |
| FY2024 Michael W. DePasquale | $309.49K | $277.10K | $273.59K | $16 | – |
| FY2023 Michael W. DePasquale | $291.53K | $261.33K | $221.55K | $28 | – |
| FY2022 | $372.08K | $254.49K | $336.21K | $26 | – |
| FY2021 | $276.94K | $265.92K | $227.33K | $63 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of the date of this report, we have forty-two employees consisting of forty-one individuals on a full-time basis and one part-time employee as follows: (i) nineteen in engineering, customer support, and research and development; (ii) nine in finance and administration; and (iii) fourteen in sales and marketing.”
Corporate history
Events identified from SEC filings